Influence of debrisoquin phenotype on the inducibility of propranolol metabolism.

Details

Serval ID
serval:BIB_61B7032FD7EA
Type
Article: article from journal or magazin.
Collection
Publications
Institution
Title
Influence of debrisoquin phenotype on the inducibility of propranolol metabolism.
Journal
Clinical Pharmacology and Therapeutics
Author(s)
Shaheen O., Biollaz J., Koshakji R.P., Wilkinson G.R., Wood A.J.
ISSN
0009-9236 (Print)
ISSN-L
0009-9236
Publication state
Published
Issued date
1989
Volume
45
Number
4
Pages
439-443
Language
english
Notes
Publication types: Journal Article ; Research Support, U.S. Gov't, P.H.S.
Publication Status: ppublish
Abstract
The effects of rifampin (600 mg) once daily for 22 days on the total and fractional metabolic clearances of propranolol were determined in a group of six genetically extensive (EM) and six poor metabolizers (PM) of debrisoquin. The impaired ability of PMs to metabolize propranolol to the ring-oxidized metabolite 4-hydroxypropranolol was confirmed. The total oral clearance of propranolol increased about fourfold in both phenotypes from 219.2 +/- 52.8 to 976.7 L/hr in the EMs and from 75.0 +/- 12.6 to 289.8 +/- 78.2 L/hr in the PMs. The extent of induction of glucuronidation was similar in the two groups. 4-Hydroxylation was induced in both phenotypes but the increase was fifteenfold greater in EMs than in PMs. This would imply that the cytochrome P-450 determined by the debrisoquin allele or some coinherited 4-hydroxylase(s) was induced to a greater extent in EMs than PMs.
Keywords
Adult, Debrisoquin/pharmacology, Enzyme Induction/drug effects, Glucuronates/urine, Humans, Isoquinolines/pharmacology, Male, Metabolic Clearance Rate/drug effects, Mixed Function Oxygenases/metabolism, Phenotype, Propranolol/analogs & derivatives, Propranolol/metabolism
Pubmed
Web of science
Create date
25/01/2008 11:41
Last modification date
20/08/2019 15:18
Usage data